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Summary
In the first half of the 20th century, in most European countries, it was thought that cholinest-
erase and other drugs that counteract acetylcholine should reduce the manifestations of schizo-
phrenia. In 1937, Fiamberti (1894–1970) introduced the transorbital method of lobotomy which 
established the use of acetylcholine shock treatment for curing the disturbances of schizophrenia.
Accepting the idea that the psychic alterations of schizophrenia were caused by a pathological 
interruption of nerve conduction at a presumably cortical level, Fiamberti thought he could 
apply this to the clinical field using the properties of acetylcholine, an acetic ester of choline.
Here, we examined, in detail, the contribution of Mario Fiamberti to acetylcholine therapy.
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Mario Fiamberti (10 September 1894-1970) was an Italian psychiatrist who 
achieved his greatest notoriety and a strong influence on psychiatry of his 
epoch. After graduating from the University of Turin, he devoted himself to 
the study of nervous and mental illnesses and to the career of asylum doctor.
He worked in the psychiatric hospitals of Brescia, Sondrio, and Vercelli, 
and became the Director of the Psychiatric Hospital of Varese since its open-
ing in 1939.
In 1937, he performed a transorbital lobotomy, by accessing the frontal 
lobe of the brain through the orbits. The technique remained rarely prac-
ticed until his reports were discovered by his contemporary, the American 
neurologist Walter Freeman, who improved the surgical technique, initially 
by using ice picks (hence the name “ice pick lobotomy”) and later employing 
more refined equipment [1,2,3,4].
In 1935, Fiamberti provoked convulsions in experimental animals by the 
administration of injections of acetylcholine, a substance capable of induc-
ing crisis, and in 1937 proposed this special method of shock for treating psy-
chotic patients. 
In neurophysiology during 1900-1950, neurohumoral knowledge of the 
time and the development of the study of chemical mediation at the level of 
brain synapses led to the formulation of many hypotheses with a superficial 
view of physiological and biological data [5].
Still today, schizophrenia represents a chronic psychotic disorder that 
continues to be controversial.
In the uncertainty of the moment, the discussion on the relationship 
between epilepsy and schizophrenia [6] began at the same time the psychi-
atric clinic scene was establishing Cardiazol, which had been introduced 
by Joseph Ladislas Meduna (1896-1964) for epileptogenic activity in 1935 
[6,7,8,9,10,11].
Originating from the idea that psychic alterations of schizophrenia 
were due to a pathological interruption of nerve conduction at cortical lev-
el, Fiamberti was convinced that he could act in the clinical field using the 
properties of acetylcholine, an acetic ester of choline. 
Fiamberti believed that acetylcholine had a fundamental role and effec-
tiveness in neural transcription. The injection of large quantities of this sub-
stance was able to, in the opinion of the Italian psychiatrist, stimulate and 
92
regulate the physiological mechanism to promote and determine the diffu-
sion of acetylcholine in the nerve centers.
The proposal for the treatment of schizophrenia with acetylcholine was 
therefore a part of the general confident adherence to the shock therapies. 
That is, the theoretical assumption continued to be that of Meduna on the 
antagonism between convulsions and schizophrenia.
The search for new substances (ammonium chloride according to the 
proposal of A. Bertolani, adrenaline according to that of V. Cacciapuoti, and 
acetylcholine according to that of Fiamberti) or other alternative methods 
for the convulsive therapy capable of inducing a state of shock were however 
stimulated by the attempt to limit adverse effects. 
Fiamberti favored the use of acetylcholine in shock therapy because of 
its theoretic implications, as well as its practical convenience and safety. 
Furthermore, Fiamberti did not report side effects.
As therapy of psychosis, the use of acetylcholine would have determined 
the clinical improvement of the patient. 
The biological activity of acetylcholine, synthesized by Nothnagel in 1894 
and isolated in the rye by Ewins in 1914, was calculated to be enormously 
superior to that of choline. 
Fiamberti presented his proposal, entitled Epileptic accesses caused by 
the introduction of substances vasodilatory under occipital, to the 21st National 
Congress of the Italian Psychiatric Society in Naples. He demonstrated that 
the introduction of an acetylcholine in an aqueous solution via the occipi-
tal route caused convulsive fits of epileptic type and therefore the substance 
seemed to be able to replace cardiazol. From these experiences, an attempt 
was born to introduce this therapeutic technique in a psychiatric clinic. 
On November 14th, 1937, at the convention on modern therapy for schizo-
phrenia in Milan, the research of Fiamberti had the explicit title Proposal of 
a new method (vascular shock) of provocation of convulsive accesses for therapeutic 
purposes with the use, for intravenous route, of acetylcholine. The first results that 
were obtained in the clinic, he considered positive, so he could make them 
public knowledge.
In February 1940, at a meeting of neurologists in Bologna, the psychiatrist 
revealed the therapeutic results obtained from 120 schizophrenic patients, 
who had been diagnosed in a less than a year, boasting that 78% of clinical 
remissions were followed by a hospital discharge. 
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The first hypotheses of Fiamberti had focused on the action of the sub-
stance on circulatory changes, so obvious to obtain the definition of “vas-
cular storm” [12]. We must note that Fiamberti considered his method of 
shock to be elective for schizophrenia, while he considered it improper in the 
dysthymic or confusional syndromes. We must remember that for certain 
manifestations of psychiatric diseases it must have been difficult to diagnose, 
with confidence, a manic depressive psychosis with hope of remission, and 
the “precocious dementia” in front of which one remained therapeutically 
in a negative position. For maniacal-depressive psychosis, Fiamberti relied 
on high-dose intravenous calcium and autohemotherapy, but in schizophre-
nia the approach was more difficult: the treatment of sulphur-therapy, pro-
tein-therapy, and the novelty of shock with insulin, and cardiazol were now 
added to acetylcholine.
There was still no revolutionary proposal of electric shock treatment by 
Ugo Cerletti.
The incomprehensibility of the dissociative phenomenon stimulated au-
dacious interpretations and gave voice to the hypothesis of a dysfunction 
of the inter-neuronal transmission due to the lack of a chemical-humoral 
mediator, the fundamental pathogenetic element. At the beginning of the 
last century, thanks to the confidence in neuropathology, it was possible to 
penetrate the etiological mechanisms of mental illnesses, the biological, bio-
electrical and clinical modifications in the main pathologies that had caused 
hospitalization in psychiatric institutions.
Fiamberti adhered unreservedly to the “pathophysiological interpretation, 
which I seem reasonable to propose to the attention of scholars, of ‘mental dissocia-
tion’ considered primitive and fundamental symptom of early dementia (Bleuler’s 
school) as an effect of a disturbed or non-transmission of nervous current at the level 
of interneuronic synapses, depending on a deficiency of acetylcholine” [13].
From this perspective, it was not difficult for Fiamberti to believe that 
with acetylcholine the synaptic nerve impulse could be modified, and act 
on dissociative symptoms. He theorized the mechanisms of action of acetyl-
choline therapy by inserting his hypothesis into the visions of a biological 
pathogenesis of schizophrenia. Understanding that the alterations of schizo-
phrenia derived from a pathological interruption of nerve conduction at the 
cortical level, it seemed that acetylcholine determined an improvement in 
dissociative symptomatology through the restoration of altered neuronal re-
lationships at the level of the central synapses with a psychic function [14]. It 
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was the neurohumoral theory of mental dissociation of psychiatric research 
and the clinic of nervous and mental diseases who expressed an almost 
unanimous adherence to these theoretical hypotheses. Fiamberti recorded 
his observations in a 450 paged manuscript, with which he obtained the 24th 
National Psychiatry Congress Award in Brazil. The injection of acetylcho-
line directly into the brain always produced a convulsive effect, however, it 
did not seem that the same effect could be obtained with intravenous ad-
ministration. All the authors agreed on this difference, furthermore, some 
experiments linked the effects on the nervous substance to the circulatory 
changes most certainly induced by the substance. Fiamberti’s proposal did 
not limit to consider the convulsive effect of acetylcholine efficacy. It reflect-
ed on the question whether it was “really necessary to get to the convulsive crisis 
or it was not enough to provoke a lighter one with diminished doses that, without 
giving convulsions, could be as effective as the therapeutic effects” [15]. He wanted 
to release his method from the necessity of the convulsive effect to channel 
it into the medical therapy on the basis of physiopathological concepts. In 
his treatment, he studied the blood chemistry parameters and the liquor be-
fore and after therapy, he studied the bioelectrical alterations of the brain, 
but the complexity of the mechanism of action was not revealed. An “ideal 
crisis” was the one accompanied by a loss of consciousness with impressive 
manifestations of vegetative and vascular order. In adults it was reached with 
the standard dose of 0.50 gram (0.40 for the lyophilized product), but it could 
also be experienced in larger doses. In the standard set of 1943, the cure con-
sisted of 100 injections, one a day with a day of rest each week, similar to 
the Sakel scheme, but prolonged or continued treatments were also practi-
cable. Intravenous injection with a large-caliber needle was to be carried out 
very quickly: in 3-5 seconds, the patient felt a sense of suffocation and turned 
from the supine position. After this first prodromal phase, the patient be-
came exhausted by a long expiratory phase in the form of frequent seizures 
of dry coughing, while the conscience became numb; in 15-20 seconds, shock 
with loss of consciousness. With or without a prolonged inhalation, the pa-
tient became rigid in a generalized tonic crisis, with hyperextension of the 
limbs (almost to configure a fleeting phase of opisthotonous), rotation of the 
head, and the ocular globes, with intense pallor, mydriasis and rigidity to 
the luminous stimulus, and wrist movement similar to the effect of cardi-
ac arrest. After another 10-15 seconds the fourth phase began, awakening: 
brief and disordered clonic shocks and imposing neurovegetative manifes-
tations; from pallor to reddening of the face, followed by sweating, tearing, 
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salivating; once the clonic shocks are over, breathing and a steady pulse are 
resumed; the recovery of consciousness was “lightning” and characterized 
by hyperlucidity. 
In all, 20-30 seconds had only passed, and the patient left the bed in a few 
minutes. This was a quick and simple method. It required the assistance of a 
single nurse in the face of the electroshock ceremony with several other fig-
ures on the scene. Fiamberti could proudly boast of it, being the most innoc-
uous of methods, despite the dramatic nature of some manifestations and 
cardiac arrest. There were no accidents, bone fractures, or late amnesia, etc. 
in 300,000 applications at the hospital of Varese. For prudence, it was bet-
ter to keep vials of atropine sulphate ready at 1 per thousand in the event of 
prolonged clinical effects. A summary of Fiamberti’s thoughts can be found 
in the study of a student of his, Edoardo Balduzzi, who published a book on 
shock therapies in 1962, dedicating about thirty pages to acetylcholine shock. 
In this text, the comparison with the other biological therapies of the time 
is presented [16]. Furthermore, a critical discussion of this treatment modal-
ity and of other shock-therapy methods with evaluating the advantages and 
disadvantages is presented in the text of Liberati [17]. Balduzzi observed that 
acetylcholine therapy had gained more confidence abroad than in Italy, with 
reports of scientific consensus from Norway, Denmark, North and South 
America, etc. and this perhaps marked a mature trait of appreciable caution 
among the Italian psychiatrists of the time. A demonstration of a direct ce-
rebral effect was given by performing experiments on animals and Giorgio 
Cenacchi, another student of Fiamberti, in 1953 tested the effect on a man 
in Varese with double electroencephalographic and electrocardiographic re-
cordings. The strong doses of acetylcholine were able to reach the encephalic 
circulation despite the cardiac arrest caused by excessive vagal stimulation. 
In the middle of the last century in psychiatric therapy, electric shock had 
dominantly imposed itself on other techniques, but Fiamberti still did not 
break away from the confident adherence to his treatment. From the hospital 
of Varese, they proposed to the community of psychiatrists apparently satis-
factory results that seemed to confirm the validity of the bio-humoral theory 
of mental dissociation and of acetylcholine treatment.
The technique was considered to be good in pure and recent dissociative 
syndromes, but mostly it was considered effective only if completed on each 
subject with at least 100 doses: “Who today, in front of a schizophrenic, espe-
cially early, does not apply the acetylcholine therapy (also associating, if he believes 
in Sakel’s therapy), in my opinion, he lacks a precise duty as a doctor, because he 
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deprives his patient of the possibility of obtaining a result that the facts show has of-
ten been achieved even when the other therapies, including that of Sakel, had failed” 
[15]. Today, on the pages of the volume from 1946 and many other works ded-
icated to acetylcholine in previous years, and in the following, we read the 
long scientific explanations at the intersection of physiology and biochem-
istry that affect our sensitivity through a series of photographs showing the 
dramatic visible effects of therapy on patients (Figure 1). “Purely for the purpose 
of documentary aid, it may be of 
some interest to submit photo-
graphic images of some patients 
performed on at the time they 
enter the hospital and when re-
covered, mostly after discharge. I 
know well how little importance 
this documentation can have on 
the demonstration side; in fact, 
the photographic technique can 
make the subjects appear differ-
ently, regardless of their attitude 
referable to particular psychic 
conditions. However, psychia-
trists may need to consider cer-
tain elements that are relative to 
the method, in particularly photographic examination, used when evaluating ex-
pressions and physiognomic attitudes with their practiced eye” [18]. It is necessary 
to report the testimony of some elderly nurses who remembered that, pre-
cisely because of the hinduostatic suffering and contortions (see the photog-
raphy), the doctors in charge of administering acetylcholine often disregard-
ed the instructions of the director of the asylum. Certainly, the ingenuity of 
the volume is surprising and together with the long casuistic and statistical 
tables, they proposed to use different photographic portraits of patients at 
the hospital admission and also after some time of care (Figure 2) [18]. Above 
all, looking at these photographs, we can better understand the testimonies 
of the nurses who were working in the Hospital of Fiamberti at that time and 
remembered that, precisely because of the obvious cenestopathic suffering 
and the patient contortions, the doctors sometimes disregarded the direc-
tor’s prescription in order to administer acetylcholine.
Figure 1. Photo showing the dramatic 
effects of therapy on patients (From 
Fiamberti AM. L’acetilcolina nelle 
sindromi schizofreniche. Interpretazione 
patogenetica della dissociazione mentale 
e sua applicazione terapeutica. Firenze: 
Niccolai; 1946).
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The signs left on the bodies and the lives of the people portrayed, like 
those of the many who have undergone coercive treatments, solicit consid-
erations regarding the ethical profiles of these practices, their impact on the 
Figure 2. Photos of patients at the hospital admission and after the cure 
(From Fiamberti AM. L’acetilcolina nelle sindromi schizofreniche. 
Interpretazione patogenetica della dissociazione mentale e sua applicazione 
terapeutica. Firenze: Niccolai; 1946).
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therapeutic relationship and, also, on the perception of psychiatry dominant 
orientation at the time.
Forty years after the introduction of the Law 180 in 1978, there have been 
many changes in ethics and rights, particularly of those vulnerable people, 
who have expressed themselves in psychiatric clinical practice [19,20]. 
The Fiamberti’s method, after a brief period of diffusion and application 
in the 1950s, quickly set for the fragility of its theoretical basis and for the 
lack of knowledge about all the specific and qualifying symptoms of schizo-
phrenia (including its subtypes). Thus, it now belongs only to the history 
of medicine and, in particular, to the non-linear and complex pathway of 
psychiatry [21,22,23].
The treatment of Fiamberti, though dated and abandoned, retains inter-
est not only as a purely historical reconstruction in the treatment of schizo-
phrenia, but also for the insights that it had.
The recent scientific research has now proven that the basis of some psy-
chiatric disorders is – including that of schizophrenia – the absence of an ap-
propriate development of neurological connections and, consequently, the 
neurological disconnection [24,25,26].
The latest scientific researches, together with the use of the new antipsy-
chotic drugs, re-propose the relationship between dopamine and cognitive 
dysfunction in schizophrenia.
Although the modulation of dopamine neurotransmission has been a 
dominant therapeutic approach, the results of both clinical and preclinical 
researches suggest that the dysregulation of other neurotransmitter systems, 
including acetylcholine, contributes to the pathophysiology of schizophre-
nia [27,28]. 
Recent research identifies the possibility that kynurenic acid is able to 
decrease the activity of acetylcholine and glutamate in brain activity.
The historical reconstruction of this treatment allows the recognition of 
the work of Fiamberti who, despite the limits of scientific and pharmacolog-
ical knowledge of that time, has identified in the acetylcholine a substance 
that plays a significant role in the antagonism of schizophrenia.
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U prvoj polovici 20. stoljeća u većini se europskih zemalja smatralo da bi kolinesteraza i dru-
gi lijekovi koji djeluju protiv acetilkolina trebali smanjiti manifestacije shizofrenije. Godine 
1937. Mario Fiamberti (1894. – 1970.) uveo je transorbitalnu metodu lobotomije koja je utvr-
dila upotrebu acetilkolinske šok-terapije u liječenju poremećaja shizofrenije. 
Prihvaćajući ideju da su psihičke promjene shizofrenije uzrokovane patološkim prekidom 
živčane provodljivosti na vjerojatno kortikalnoj razini, Fiamberti je mislio da to može primi-
jeniti na kliničkom polju koristeći svojstva acetilkolina, acetilnog ester kolina.
U istraživanju je detaljno ispitan doprinos Marija Fiambertija u terapiji acetilkolinom.
Ključne riječi: acetilkolin terapija; Fiambertijeva metoda; acetilkolinski šok; shizofrenija i 
interpretativna hipoteza; nedostatak acetilkolina; shizofrenija
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